IBJ Podcast: Lilly in middle of big battle over future of drug prices for seniors

  • Comments
  • Print
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
This audio file is brought to you by
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00


The health care industry in America is on the precipice of its biggest change at least since the passage of Obamacare 13 years ago.

Passed last summer, the Inflation Reduction Act has given Medicare the green light to negotiate the prices of some drugs for its 60 million-some recipients. The program is expected to save patients many billions of dollars while significantly shrinking revenue for some pharmaceutical firms.

Indianapolis-based Eli Lilly and Co. is intensely concerned about the development. Two of its most popular medicines are expected to be among the first 40 drugs subject to negotiations.

Lilly CEO David Ricks has gone on the record in public forums criticizing the new law for what he anticipates will be a chilling effect on the development of certain types of drugs. Meanwhile, other big players in the pharmaceutical industry are trying to squash the negotiations altogether. Two have sued the Biden administration, asking a federal judge to declare the program unconstitutional.

IBJ reporter John Russell has been studying the program for a story that’s on the front page of the latest issue of IBJ. In this week’s edition of the IBJ Podcast, Russell discusses the program’s potential effects on patients, drug makers and the rest the health care industry, as well as the objections from Eli Lilly and Co.

Click here to find the IBJ Podcast each Monday. You can also subscribe at iTunesGoogle PlayTune In, Spotify and anyplace you find podcasts.

You can also listen to these recent episodes:

IBJ Podcast: Brian Payne on the Cultural Trail, equity, fighting systemic racism and leaving CICF

IBJ Podcast: Couple behind Wild Birds Unlimited risked $5.5M to turn golf course into Zionsville nature preserve

IBJ Podcast: Pete The Planner on potential student loan tumult and its wider economic threats

IBJ Podcast: Why does downtown need a $90M sports arena, in addition to its NBA and NFL venues?

IBJ Podcast: Indiana becoming garden spot for vital ag innovation, food security

Please enable JavaScript to view this content.

Story Continues Below

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

Get the best of Indiana business news. ONLY $1/week Subscribe Now

Get the best of Indiana business news. ONLY $1/week Subscribe Now

Get the best of Indiana business news. ONLY $1/week Subscribe Now

Get the best of Indiana business news. ONLY $1/week Subscribe Now

Get the best of Indiana business news.

Limited-time introductory offer for new subscribers

ONLY $1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Get the best of Indiana business news.

Limited-time introductory offer for new subscribers

ONLY $1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Get the best of Indiana business news.

Limited-time introductory offer for new subscribers

ONLY $1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Get the best of Indiana business news.

Limited-time introductory offer for new subscribers

ONLY $1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In